Skip to main content

C1 esterase inhibitor (human) Pregnancy and Breastfeeding Warnings

Medically reviewed by Drugs.com. Last updated on Nov 16, 2022.

C1 esterase inhibitor (human) is also known as: Berinert, Cinryze, Haegarda

C1 esterase inhibitor (human) Pregnancy Warnings

Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.

FDA pregnancy category: C

Use only if clearly needed and benefit outweighs potential risk.

See references

C1 esterase inhibitor (human) Breastfeeding Warnings

Caution is recommended

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Cinryze (C1 esterase inhibitor, human)." ViroPharma Incorporated (2022):

References for breastfeeding information

  1. "Product Information. Cinryze (C1 esterase inhibitor, human)." ViroPharma Incorporated (2022):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.